New biotechnology park in Spata: An 80 million euro investment
The creation of the Athens Life Tech Park (ALTP) marks a significant development for the health and technology sector in Greece. It is the first integrated biotechnology park in Southeast Europe, located in Spata, Attica.
The 80 million euro investment was made by the Greek pharmaceutical company ELPEN. This project aims to strengthen the research and development of new drugs, placing Greece at the center of developments in the life sciences sector.
The new park includes modern facilities that will house research laboratories and high-level technological infrastructure. The goal is to foster collaboration between scientists, researchers, and businesses to produce innovative solutions in the healthcare field.
The operation of the ALTP is expected to create new jobs for specialized personnel, such as scientists and researchers. At the same time, this investment strengthens our country's role as an innovation hub in the wider region.
In conclusion, the Athens Life Tech Park represents a significant step for the development of the Greek economy. Through this initiative, Greece is strengthening its capabilities in research and production, offering new prospects in the field of pharmaceutical technology.